Browsing by Author "Packer, Catherine"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and Senegal
    (Contraception, 2014) Burkea, Holly M.; Mueller, Monique P.; Perry, Brian; Packer, Catherine; Bufumbo, Leonard; Mbengue, Daouda; Mall, Ibrahima; Mamadou Daff, Bocar; Mbonye, Anthony K.
    Sayana® Press (SP), a subcutaneous formulation of depot medroxyprogesterone acetate (DMPA) in Uniject™, has potential to be a valuable innovation in family planning (FP) because it may overcome logistic and safety challenges in delivering intramuscular DMPA (DMPA IM). However, SP's acceptability is unknown. We measured acceptability of SP among DMPA IM users. Study design: This open-label observational study was conducted in clinics in three districts in Senegal and community-based distribution services in two districts in Uganda. Experienced DMPA IM users were offered SP by community health workers (CHWs) or clinic-based providers. SP decliners were asked to discuss their reasons. Those who received SP were interviewed pre- and post injection and 3 months later, when they were asked if they would select SP over DMPA IM if it were available.
  • Thumbnail Image
    Item
    Provider acceptability of Sayana® Press: results from community health workers and clinic-based providers in Uganda and Senegal
    (Contraception, 2014) Burke, Holly M.; Mueller, Monique P.; Packer, Catherine; Perry, Brian; Bufumbo, Leonard; Mbengue, Daouda; Mamadou Daff, Bocar; Mbonye, Anthony
    Sayana® Press (SP), a subcutaneous formulation of depot medroxyprogesterone acetate (DMPA) in Uniject™, has potential to be a valuable innovation in family planning (FP) because it may overcome logistic and safety challenges in delivering intramuscular DMPA (DMPA IM). However, SP's acceptability is unknown. We measured acceptability of SP among clinic-based providers (Senegal only) and community health workers. Study design: This open-label observational study was conducted in clinics in three districts in Senegal and community-based services in two districts in Uganda. Providers administered SP to clients seeking reinjection of DMPA IM. We conducted in-depth interviews with 86 providers (52 in Senegal, 34 in Uganda) to assess their experiences providing SP to clients.